| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 41.9746 | 13 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.2848 | 33 |
| GSM780709 | Untreated after 4 days (C3_1) | 41.6694 | 12 |
| GSM780719 | Untreated after 4 days (C1_2) | 44.9767 | 27 |
| GSM780720 | Untreated after 4 days (C2_2) | 47.0158 | 37 |
| GSM780721 | Untreated after 4 days (C3_2) | 42.9229 | 17 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 44.619 | 25 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.4062 | 34 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 46.9175 | 36 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 42.1774 | 14 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 48.3328 | 42 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 44.6723 | 25 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 44.2686 | 23 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 40.1754 | 7 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 43.8233 | 21 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 43.4516 | 20 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 43.0937 | 18 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 41.0698 | 10 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 39.0673 | 4 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 40.9399 | 9 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 43.5163 | 20 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 50.001 | 48 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 45.9405 | 32 |